Holen Sie sich die Stockscreener-App
295.87
0.38%
1.11
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$294.76
Offen:
$294.75
24-Stunden-Volumen:
2.02M
Relative Volume:
0.75
Marktkapitalisierung:
$159.09B
Einnahmen:
$34.13B
Nettoeinkommen (Verlust:
$5.93B
KGV:
27.00
EPS:
10.96
Netto-Cashflow:
$10.92B
1W Leistung:
-0.39%
1M Leistung:
+2.26%
6M Leistung:
+7.66%
1J Leistung:
-10.69%
1-Tages-Spanne:
$293.60
$297.09
1-Wochen-Bereich:
$291.94
$301.00
52-Wochen-Spanne:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
295.87 | 159.71B | 34.13B | 5.93B | 10.92B | 10.96 |
|
LLY
Lilly Eli Co
|
762.18 | 717.60B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
164.36 | 377.32B | 90.63B | 22.66B | 18.57B | 9.35 |
|
ABBV
Abbvie Inc
|
184.85 | 338.30B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
114.14 | 234.32B | 55.19B | 13.65B | 16.81B | 6.86 |
|
NVO
Novo Nordisk Adr
|
64.92 | 306.33B | 43.59B | 15.04B | 10.74B | 3.3766 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen Inc. (NASDAQ:AMGN) Stock Position Lowered by Morningstar Investment Services LLC - MarketBeat
SNS Financial Group LLC Decreases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Stock Acquired Rep. Cliff Bentz - MarketBeat
Evergreen Wealth Management LLC Acquires 3,592 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Private Advisor Group LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Lobbying Update: $2,580,000 of AMGEN INC lobbying was just disclosed - Quiver Quantitative
Amgen’s Promising Study on Advanced Gastric Cancer: What Investors Need to Know - TipRanks
Amgen’s Jyothis George named NodThera CMO - The Pharma Letter
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Arrow Financial Corp - MarketBeat
Humira Biosimilar Market Gains Momentum Post-Patent Expiry & - openPR.com
Peregrine Asset Advisers Inc. Reduces Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
J.W. Cole Advisors Inc. Has $3.60 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer - GlobeNewswire Inc.
Larson Financial Group LLC Boosts Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
What drives Amgen Inc. stock priceUnprecedented market success - Autocar Professional
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Forum Financial Management LP - MarketBeat
Amgen Stock (AMGN) Opinions on Recent Price Declines and Technical Trends - Quiver Quantitative
Los Angeles Capital Management LLC Increases Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Wealth Alliance LLC Acquires 999 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Souders Financial Advisors Sells 4,633 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Heritage Investors Management Corp Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Teachers Retirement System of The State of Kentucky Acquires 1,839 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Twin Capital Management Inc. Has $6.24 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Position Raised by OneAscent Financial Services LLC - MarketBeat
Elyxium Wealth LLC Invests $618,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Copperwynd Financial LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cullen Frost Bankers Inc. Purchases 4,162 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Montrusco Bolton Investments Inc. Has $210.72 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
What analysts say about Amgen Inc. stockConsistent double returns - jammulinksnews.com
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Commerzbank Aktiengesellschaft FI - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Verdence Capital Advisors LLC - MarketBeat
Parcion Private Wealth LLC Sells 1,188 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. Stock Analysis and ForecastPhenomenal wealth increase - Autocar Professional
Concord Wealth Partners Has $3.09 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Is Amgen Inc. a good long term investmentRapid market gains - jammulinksnews.com
Balentine LLC Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by St. Louis Trust Co - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Cut by Jennison Associates LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Edgestream Partners L.P. - MarketBeat
Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025 - Yahoo Finance
Amgen (AMGN) Declines More Than Market: Some Information for Investors - Yahoo Finance
Leo Wealth LLC Sells 1,746 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
HSBC Trims Amgen (AMGN) Price Target, Maintains Buy Rating - MSN
Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More - Seeking Alpha
Amgen’s Phase 3 Study on Etelcalcetide: A Potential Game-Changer for Pediatric Kidney Disease - TipRanks
Amgen’s New Study on SCLC Treatment: A Potential Game Changer? - TipRanks
Amgen’s AMG 193 Study: A Potential Game-Changer in Thoracic Tumor Treatment - TipRanks
Amgen’s Romiplostim Study: A Potential Game-Changer for Chemotherapy Patients - TipRanks
Will Amgen Inc. stock benefit from interest rate changes2x 3x 5x Pick Alert - beatles.ru
Amgen’s Promising Phase 3 Study: Maridebart Cafraglutide for Obesity in Type 2 Diabetes - TipRanks
Amgen’s Avacopan Study: A Potential Game-Changer in Vasculitis Treatment - TipRanks
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):